Stock Analysis
Align Technology, Inc. (ALGN) Stock Analysis
Align Technology, Inc. (ALGN) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Align Technology, Inc. (ALGN) currently has an AIQ Score of 67/100, indicating a neutral setup. Momentum is the strongest factor at 76/100. Sentiment is the weakest current factor at 51/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
ALGN at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $149.89 |
| AIQ Score | 67/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $11.1B |
| P/E Ratio (TTM) | 26.9 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $1.51 |
| Revenue (quarter ended 2026-06-30) | $1.06B |
| Dividend Yield (TTM) | 0.00% |
| Beta | 1.65 |
| Volume | 1.13M |
| 52-week range | $130.23-$200.44 |
| RSI 14 | 70.55 |
| 50-Day SMA | $150.64 |
| 200-Day SMA | $168.91 |
| Analyst Price Target | $192.50 |
| Next Earnings | Feb 3, 2027 |
ALGNAlign Technology, Inc.
Healthcare / Medical - Devices
Leader
Strong Relative Position
Latest quote
- Momentum76
- Value62
- Quality70
- Risk resilience57
- Sentiment51
ALGN Stock Analysis Summary
Align Technology, Inc. (ALGN) currently has an AIQ Score of 67/100, indicating a neutral setup. Momentum is the strongest factor at 76/100. Sentiment is the weakest current factor at 51/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, ALGN has AIQ Score of 67/100 with Momentum base of 76/100 and fading Sentiment at 51/100. Wait for component alignment before adding exposure.
Momentum (76/100) leads while Sentiment (51/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -2.49% stock move · ALGN classified in Medical - Devices.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is ALGN Bullish or Bearish Right Now?
ALGN currently has a neutral overall setup. Momentum is the strongest factor at 76/100, while Sentiment is weakest at 51/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 70/100.
- - Momentum is constructive at 76/100.
- - Price is +2.04% above its 50-day SMA.
- - Analyst target implies +28.43% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (33 vs 10).
- - Price is -9.00% below its 200-day SMA.
Current Consensus
ALGN's Technical Analysis Consensus is currently Strong Buy, with 33 buy, 2 neutral, and 10 sell votes. ALGN's 14-day RSI is 70.55, which places the stock in an overbought momentum range. ALGN's beta is 1.65, indicating greater market sensitivity than the broad market.
What Changed in ALGN?
The largest recent change in ALGN is Momentum moving down by 2.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the ALGN Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
ALGN Decision Framework
Public evidence layers, setup checks, and risk context for Align Technology, Inc..
Align Technology, Inc. (ALGN) Stock Analysis
Align Technology, Inc. has an AIQ Score of 67/100 in a Neutral regime. Momentum is strongest at 76/100. Beta is 1.67, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | ALGN is in a Neutral AIQ regime with score 67/100. |
| Signal Conflict | The primary conflict is that momentum leads at 76/100 while sentiment lags at 51/100. |
| Factor Evidence | Momentum 76/100 · Value 62/100 · Quality 70/100 · Risk 57/100 · Sentiment 51/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 76/100.
Momentum is 76/100 and RSI (14) is 70.6.
ALGN is in a Neutral regime at 67/100.
Risk factor is 57/100 with beta 1.67 and annual volatility 39.27%.
Current conflict: momentum leads at 76/100 while sentiment lags at 51/100.
ALGN Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
ALGN Fundamentals
ALGN valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
ALGN Technical Analysis
ALGN technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
ALGN Stock Catalysts
Track ALGN earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
ALGN Dividend Analysis
ALGN dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
ALGN Financial Data
ALGN revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
ALGN Risk Analysis
ALGN volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
ALGN Stock News
ALGN stock news, market tone, recent headlines, and catalyst context.
ALGN vs Medical Devices Peers
Current peer cohort: ALGN · AVTR · BAX · BDX · BSX. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| ALGN Current stock | 67/100 | 62/100 | 76/100 | 57/100 | 0.49 | 39.27% | Current |
| AVTR Avantor | 57/100 | 63/100 | 75/100 | 62/100 | 0.96 | 43.75% | ALGN vs AVTR |
| BAX Baxter International | 44/100 | 69/100 | 43/100 | 46/100 | 0.24 | 43.98% | ALGN vs BAX |
| BDX Becton Dickinson | 59/100 | 63/100 | 80/100 | 49/100 | 0.32 | 30.97% | ALGN vs BDX |
| BSX Boston Scientific | 55/100 | 58/100 | 41/100 | 48/100 | -2.1 | 38.88% | ALGN vs BSX |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching ALGN
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for ALGN
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
ALGN Stock FAQ
What is ALGN stock price today?
Align Technology, Inc.'s current stock price is $149.89. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is ALGN bullish or bearish right now?
ALGN's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is ALGN's market cap?
ALGN's market cap is $11.1B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is ALGN's current P/E ratio?
ALGN's current P/E ratio is 26.9 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is ALGN's RSI?
ALGN's 14-day RSI is 70.55 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is ALGN above its 50-day and 200-day moving averages?
ALGN is 2.04% from its 50-day SMA and -9.00% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is ALGN's next earnings date?
ALGN's next earnings date is currently listed as Feb 3, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does ALGN pay a dividend?
ALGN's dividend yield is 0.00% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.